More tools:Markets·Screener·Research·Chat

Bruker Corporation (BRKR) Financial Statements

Bruker Corporation
SIC 3826 · LABORATORY ANALYTICAL INSTRUMENTS
FIGI BBG001SF69P0
XNAS · usd
58.37▼ 0.13 (-0.22%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close58.50
Day's Range56.80 – 58.57
52-Week Range29.84 – 65.30
Volume1.0M
Avg Volume2.2M
Share Statistics
Shares Outstanding
Employees11.1K
ExchangeXNAS
Listed2000-08-04
Share count as of August 3, 2026
Loading Income Statement…
Key questions about Bruker Corporation (BRKR)
What is Bruker Corporation's Market Cap?
Bruker Corporation's Market Cap is $9.1B, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's Enterprise Value?
Bruker Corporation's Enterprise Value is $10.7B, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's Price / Sales?
Bruker Corporation's Price / Sales is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's EV / Revenue?
Bruker Corporation's EV / Revenue is 3.1×, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's EV / EBITDA?
Bruker Corporation's EV / EBITDA is 53.7×, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's Revenue (TTM)?
Bruker Corporation's Revenue (TTM) is $3.5B, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's Net Income (TTM)?
Bruker Corporation's Net Income (TTM) is -$106.9M, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's EBITDA?
Bruker Corporation's EBITDA is $199.5M, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's Diluted EPS (TTM)?
Bruker Corporation's Diluted EPS (TTM) is -0.69, based on as-reported figures from SEC (XBRL) filings.
What is Bruker Corporation's EBITDA Margin?
Bruker Corporation's EBITDA Margin is 5.7%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Mar 31, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
Total revenue
YoY growth+5.2%+2.7%-0.2%-0.5%
Total cost of revenue
Gross profit
% of revenue49.6%46.1%46.0%44.1%
Operating expenses:
Selling, general and administrative
Research and development
Goodwill impairment charge—
Other charges, net——
Total operating expenses
% of revenue57.4%44.9%38.2%50.1%
Operating (loss) income
% of revenue-7.8%1.2%7.8%-6.0%
Interest and other income (expense), net
(Loss) income before income taxes, equity in income of unconsolidated investees, net of tax, and noncontrolling interests in consolidated subsidiaries
Income tax provision (benefit)
Equity in income of unconsolidated investees, net of tax
Consolidated net (loss) income
% of revenue-6.1%1.9%3.0%-6.8%
Net income (loss) attributable to noncontrolling interests in consolidated subsidiaries
Net (loss) income attributable to Bruker Corporation
% of revenue-6.2%1.7%2.7%-6.9%
Dividends on Series A Mandatory Convertible Preferred Stock
Net (loss) income attributable to Bruker Corporation common shareholders
Net (loss) income per common share attributable to Bruker Corporation common shareholders:
Basic
Diluted